HOOKIPA Pharma Inc.

The momentum for this stock is not very good. HOOKIPA Pharma Inc. has good growth characteristics. HOOKIPA Pharma Inc. is a mediocre stock to choose.

News

Wall Street Analysts Think HOOKIPA Pharma (HOOK) Could Surge 622.75%: Read This Before Placing a Bet

Zacks Investment Research HOOKIPA Pharma Inc. (HOOK) closed the last trading session at $5.23, gaining 1.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by...\n more…

Hookipa Pharma appoints O'Neill as non-executive chair of board

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

HOOKIPA Pharma Announces Board of Directors Changes

Globe Newswire NEW YORK and VIENNA, Aug. 30, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) ( HOOKIPA or the Company ), a company developing a new class of immunotherapeutics based on its...\n more…

The Market Doesn't Like What It Sees From HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Revenues Yet As Shares Tumble 29%

Simply Wall St To the annoyance of some shareholders, HOOKIPA Pharma Inc. ( NASDAQ:HOOK ) shares are down a considerable 29% in the...\n more…

HOOK Stock Earnings: HOOKIPA Pharma Misses EPS, Misses Revenue for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nHOOK stock results show that HOOKIPA Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter...\n more…